Fulgent Genetics (FLGT) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Fulgent Genetics Revenue Highlights


Latest Revenue (Y)

$289.21M

Latest Revenue (Q)

$71.03M

Main Geography (Y)

UNITED STATES

Fulgent Genetics Revenue by Period


Fulgent Genetics Revenue by Year

DateRevenueChange
2023-12-31$289.21M-53.27%
2022-12-31$618.97M-37.64%
2021-12-31$992.58M135.37%
2020-12-31$421.71M1196.46%
2019-12-31$32.53M52.31%
2018-12-31$21.36M14.03%
2017-12-31$18.73M2.48%
2016-12-31$18.28M90.85%
2015-12-31$9.58M649.30%
2014-12-31$1.28M100.00%
2001-12-31--

Fulgent Genetics generated $289.21M in revenue during NA 2023, up -53.27% compared to the previous quarter, and up 1354.18% compared to the same period a year ago.

Fulgent Genetics Revenue by Quarter

DateRevenueChange
2024-06-30$71.03M10.15%
2024-03-31$64.48M-8.54%
2023-12-31$70.50M-16.75%
2023-09-30$84.69M24.81%
2023-06-30$67.85M2.55%
2023-03-31$66.17M-2.27%
2022-12-31$67.70M-35.92%
2022-09-30$105.66M-15.71%
2022-06-30$125.34M-60.86%
2022-03-31$320.27M27.26%
2021-12-31$251.67M10.45%
2021-09-30$227.87M48.34%
2021-06-30$153.62M-57.26%
2021-03-31$359.43M21.85%
2020-12-31$294.98M190.00%
2020-09-30$101.72M489.15%
2020-06-30$17.27M122.69%
2020-03-31$7.75M-7.56%
2019-12-31$8.39M-18.94%
2019-09-30$10.35M22.83%
2019-06-30$8.42M56.87%
2019-03-31$5.37M-5.44%
2018-12-31$5.68M0.96%
2018-09-30$5.63M4.17%
2018-06-30$5.40M16.05%
2018-03-31$4.65M8.69%
2017-12-31$4.28M-4.93%
2017-09-30$4.50M-2.95%
2017-06-30$4.64M-12.55%
2017-03-31$5.31M-9.36%
2016-12-31$5.85M16.82%
2016-09-30$5.01M26.19%
2016-06-30$3.97M15.44%
2016-03-31$3.44M18.58%
2015-12-31$2.90M-0.14%
2015-09-30$2.90M-

Fulgent Genetics generated $71.03M in revenue during Q2 2024, up 10.15% compared to the previous quarter, and up 107.34% compared to the same period a year ago.

Fulgent Genetics Revenue Breakdown


Fulgent Genetics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 24Mar 18
Laboratory Services$71.03M-
Genetic Testing Services-$4.65M

Fulgent Genetics's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Laboratory Services (100.00%).

Fulgent Genetics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20Dec 19Dec 18
UNITED STATES$978.98M$415.33M$25.01M$12.58M
Non Us$13.61M---
CANADA-$1.73M$2.25M$3.98M
Other Countries-$4.65M$5.27M$4.68M
CHINA---$109.00K

Fulgent Genetics's latest annual revenue breakdown by geography, as of Dec 21: UNITED STATES (98.63%), and Non Us (1.37%).

Quarterly Revenue by Country

CountryJun 24Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Sep 18Jun 18Mar 18
CHINA$2.48M$23.00K$25.00K$24.00K------------
UNITED STATES$64.19M$247.89M$149.86M$357.54M$293.33M$100.22M$16.14M$5.64M$6.24M$8.48M$6.69M$3.61M$3.27M$3.30M$2.53M-
Other Countries$4.36M$1.24M$1.12M$798.00K$1.50M$1.51M$1.32M$1.22M$1.22M$1.21M$1.01M$1.13M----
Non-US$6.83M---------------
Non Us-$3.78M$4.18M$3.75M$1.89M-----------
U S--$223.69M-------------
CANADA-----$401.00K$376.00K$329.00K$619.00K$643.00K$548.00K$516.00K$538.00K$1.12M$1.07M$970.00K
Genetic Testing Services---------------$73.00K

Fulgent Genetics's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (82.45%), Non-US (8.78%), Other Countries (5.60%), and CHINA (3.18%).

Fulgent Genetics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TMOThermo Fisher Scientific$42.86B$10.54B
DHRDanaher$14.03B$3.43B
AAgilent$6.83B$1.58B
ILMNIllumina$4.50B$1.08B
CRLCharles River Laboratories$4.13B$1.03B
MTDMettler-Toledo$3.79B$946.75M
WATWaters$2.96B$708.53M
EXASExact Sciences$2.50B$699.26M
NTRANatera$1.08B$413.35M
GHGuardant Health$563.95M$177.24M
FLGTFulgent Genetics$289.21M$71.03M
CDNACareDx$280.32M$92.27M
TWSTTwist Bioscience$245.11M$81.46M
TTOOT2 Biosystems$7.19M$1.95M

FLGT Revenue FAQ


Fulgent Genetics's yearly revenue for 2023 was $289.21M, representing a decrease of -53.27% compared to 2022. The company's yearly revenue for 2022 was $618.97M, representing a decrease of -37.64% compared to 2021. FLGT's yearly revenue for 2021 was $992.58M, representing an increase of 135.37% compared to 2020.

Fulgent Genetics's quarterly revenue for Q2 2024 was $71.03M, a 10.15% increase from the previous quarter (Q1 2024), and a 4.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $64.48M, a -8.54% decrease from the previous quarter (Q4 2023), and a -2.54% decrease year-over-year (Q1 2023). FLGT's quarterly revenue for Q4 2023 was $70.5M, a -16.75% decrease from the previous quarter (Q3 2023), and a 4.14% increase year-over-year (Q4 2022).

Fulgent Genetics's revenue growth rate for the last 3 years (2021-2023) was -70.86%, and for the last 5 years (2019-2023) was 789.12%.